[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.207.116. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
July 2005

Recalcitrant Cutaneous Sarcoidosis Responding to Infliximab

Arch Dermatol. 2005;141(7):910-911. doi:10.1001/archderm.141.7.910

Sarcoidosis is a multisystem disease, manifesting with cutaneous involvement in approximately 25% of patients.1 Lesions present in a wide variety of forms, including lupus pernio, violaceous papules and plaques, subcutaneous nodules, alopecia, ichthyosis, or verrucous growths. We describe a woman with cutaneous sarcoidosis refractory to treatment with multiple systemic agents who improved dramatically with infliximab therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×